Skip to main content
Top
Published in: BMC Public Health 1/2013

Open Access 01-12-2013 | Research article

Health-related quality of life in adolescents with screening-detected celiac disease, before and one year after diagnosis and initiation of gluten-free diet, a prospective nested case-referent study

Authors: Katrina Nordyke, Fredrik Norström, Lars Lindholm, Hans Stenlund, Anna Rosén, Anneli Ivarsson

Published in: BMC Public Health | Issue 1/2013

Login to get access

Abstract

Background

Celiac disease (CD) is a chronic disorder in genetically predisposed individuals in which a small intestinal immune-mediated enteropathy is precipitated by dietary gluten. It can be difficult to diagnose because signs and symptoms may be absent, subtle, or not recognized as CD related and therefore not prompt testing within routine clinical practice. Thus, most people with CD are undiagnosed and a public health intervention, which involves screening the general population, is an option to find those with unrecognized CD. However, how these screening-detected individuals experience the diagnosis and treatment (gluten-free diet) is not fully understood. The aim of this study is to investigate the health-related quality of life (HRQoL) of adolescents with screening-detected CD before and one year after diagnosis and treatment.

Methods

A prospective nested case-referent study was done involving Swedish adolescents who had participated in a CD screening study when they were in the sixth grade and about 12 years old. Screening-detected adolescents (n = 103) and referents without CD who participated in the same screening (n = 483) answered questionnaires at the time of the screening and approximately one year after the screening-detected adolescents had received their diagnosis that included the EQ-5D instrument used to measure health status and report HRQoL.

Results

The HRQoL for the adolescents with screening-detected CD is similar to the referents, both before and one year after diagnosis and initiation of the gluten-free diet, except in the dimension of pain at follow-up. In the pain dimension at follow-up, fewer cases reported problems than referents (12.6% and 21.9% respectively, Adjusted OR 0.50, 95% CI 0.27-0.94). However, a sex stratified analysis revealed that the significant difference was for boys at follow-up, where fewer screening-detected boys reported problems (4.3%) compared to referent boys (18.8%) (Adjusted OR 0.17, 95% CI 0.04-0.73).

Conclusions

The findings of this study suggest that adolescents with unrecognized CD experience similar HRQoL as their peers without CD, both before and one year after diagnosis and initiation of gluten-free diet, except for boys in the dimension of pain at follow-up.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ludvigsson JF, Leffler DA, Bai JC, Biagi F, Fasano A, Green PHR, Hadjivassiliou M, Kaukinen K, Kelly CP, Leonard JN, et al: The Oslo definitions for coeliac disease and related terms. Gut. 2012, 62: 43-52.CrossRefPubMedPubMedCentral Ludvigsson JF, Leffler DA, Bai JC, Biagi F, Fasano A, Green PHR, Hadjivassiliou M, Kaukinen K, Kelly CP, Leonard JN, et al: The Oslo definitions for coeliac disease and related terms. Gut. 2012, 62: 43-52.CrossRefPubMedPubMedCentral
2.
go back to reference Newton K, Singer S: Celiac disease in children and adolescents: special considerations. Semin Immunopathol. 2012, 34: 479-496. 10.1007/s00281-012-0313-0.CrossRefPubMed Newton K, Singer S: Celiac disease in children and adolescents: special considerations. Semin Immunopathol. 2012, 34: 479-496. 10.1007/s00281-012-0313-0.CrossRefPubMed
3.
go back to reference Aggarwal S, Lebwohl B, Green PHR: Screening for celiac disease in average-risk and high-risk populations. Ther Adv Gastroenterol. 2012, 5: 37-47. 10.1177/1756283X11417038.CrossRef Aggarwal S, Lebwohl B, Green PHR: Screening for celiac disease in average-risk and high-risk populations. Ther Adv Gastroenterol. 2012, 5: 37-47. 10.1177/1756283X11417038.CrossRef
4.
go back to reference Fasano A, Berti I, Gerarduzzi T: Prevalence of celiac disease in at-risk and not-at risk groups in the United States. Arch Intern Med. 2003, 163: 286-292. 10.1001/archinte.163.3.286.CrossRefPubMed Fasano A, Berti I, Gerarduzzi T: Prevalence of celiac disease in at-risk and not-at risk groups in the United States. Arch Intern Med. 2003, 163: 286-292. 10.1001/archinte.163.3.286.CrossRefPubMed
5.
go back to reference Rubio-Tapia A, Kyle RA, Kaplan EL, Johnson DR, Page W, Erdtmann F, Brantner TL, Kim WR, Phelps TK, Lahr BD, et al: Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology. 2009, 137: 88-93. 10.1053/j.gastro.2009.03.059.CrossRefPubMedPubMedCentral Rubio-Tapia A, Kyle RA, Kaplan EL, Johnson DR, Page W, Erdtmann F, Brantner TL, Kim WR, Phelps TK, Lahr BD, et al: Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology. 2009, 137: 88-93. 10.1053/j.gastro.2009.03.059.CrossRefPubMedPubMedCentral
6.
go back to reference Lohi S, Mustalahti K, Kaukinen K, et al: Increasing prevalence of coeliac disease over time. Aliment Pharmacol Ther. 2007, 26: 1217-1225. 10.1111/j.1365-2036.2007.03502.x.CrossRefPubMed Lohi S, Mustalahti K, Kaukinen K, et al: Increasing prevalence of coeliac disease over time. Aliment Pharmacol Ther. 2007, 26: 1217-1225. 10.1111/j.1365-2036.2007.03502.x.CrossRefPubMed
7.
go back to reference Mearin L, Ivarsson A, Dickey W: Coelic disease: is it time for mass screening?. Best Pract Res Clin Gastroenterol. 2005, 19: 441-452. 10.1016/j.bpg.2005.02.004.CrossRefPubMed Mearin L, Ivarsson A, Dickey W: Coelic disease: is it time for mass screening?. Best Pract Res Clin Gastroenterol. 2005, 19: 441-452. 10.1016/j.bpg.2005.02.004.CrossRefPubMed
8.
go back to reference Myléus A, Ivarsson A, Webb C, Danielsson L, Hernell O, Högberg L, Karlsson E, Lagerqvist C, Norström F, Rosén A, et al: Celiac disease revealed in 3% of swedish 12-year-olds born during an epidemic. J Pediatr Gastroenterol Nutr. 2009, 49: 170-176. 10.1097/MPG.0b013e31818c52cc.CrossRefPubMed Myléus A, Ivarsson A, Webb C, Danielsson L, Hernell O, Högberg L, Karlsson E, Lagerqvist C, Norström F, Rosén A, et al: Celiac disease revealed in 3% of swedish 12-year-olds born during an epidemic. J Pediatr Gastroenterol Nutr. 2009, 49: 170-176. 10.1097/MPG.0b013e31818c52cc.CrossRefPubMed
9.
go back to reference Ivarsson A, Persson LÅ, Juto P, Peltonen M, Suhr O, Hernell O: High prevalence of undiagnosed coeliac disease in adults: a Swedish population-based study. J Intern Med. 1999, 245: 63-68. 10.1046/j.1365-2796.1999.00403.x.CrossRefPubMed Ivarsson A, Persson LÅ, Juto P, Peltonen M, Suhr O, Hernell O: High prevalence of undiagnosed coeliac disease in adults: a Swedish population-based study. J Intern Med. 1999, 245: 63-68. 10.1046/j.1365-2796.1999.00403.x.CrossRefPubMed
10.
go back to reference Rubio-Tapia A, Ludvigsson JF, Brantner TL, Murray JA, Everhart JE: The prevalence of celiac disease in the United States. Am J Gastroenterol. 2012, 107: 1538-1544. 10.1038/ajg.2012.219.CrossRefPubMed Rubio-Tapia A, Ludvigsson JF, Brantner TL, Murray JA, Everhart JE: The prevalence of celiac disease in the United States. Am J Gastroenterol. 2012, 107: 1538-1544. 10.1038/ajg.2012.219.CrossRefPubMed
11.
go back to reference Green PHR: The many faces of celiac disease: clinical presentation of celiac disease in the adult population. Gastroenterology. 2005, 128: S74-S78. 10.1053/j.gastro.2005.02.016.CrossRefPubMed Green PHR: The many faces of celiac disease: clinical presentation of celiac disease in the adult population. Gastroenterology. 2005, 128: S74-S78. 10.1053/j.gastro.2005.02.016.CrossRefPubMed
12.
go back to reference Fasano A: Should we screen for coeliac disease? Yes. BMJ. 2009, 339: 998-999.CrossRef Fasano A: Should we screen for coeliac disease? Yes. BMJ. 2009, 339: 998-999.CrossRef
13.
go back to reference Rubio-Tapia A, Van Dyke CT, Lahr BD, Zinsmeister AR, El-Youssef M, Moore SB, Bowman M, Burgart LJ, Melton Iii LJ, Murray JA: Predictors of family risk for celiac disease: a population-based study. Clin Gastroenterol Hepatol. 2008, 6: 983-987. 10.1016/j.cgh.2008.04.008.CrossRefPubMedPubMedCentral Rubio-Tapia A, Van Dyke CT, Lahr BD, Zinsmeister AR, El-Youssef M, Moore SB, Bowman M, Burgart LJ, Melton Iii LJ, Murray JA: Predictors of family risk for celiac disease: a population-based study. Clin Gastroenterol Hepatol. 2008, 6: 983-987. 10.1016/j.cgh.2008.04.008.CrossRefPubMedPubMedCentral
14.
go back to reference Gray A, Papanicolas I: Impact of symptoms on quality of life before and after diagnosis of coeliac disease: results from a UK population survey. BMC Health Serv Res. 2010, 10: 105-10.1186/1472-6963-10-105.CrossRefPubMedPubMedCentral Gray A, Papanicolas I: Impact of symptoms on quality of life before and after diagnosis of coeliac disease: results from a UK population survey. BMC Health Serv Res. 2010, 10: 105-10.1186/1472-6963-10-105.CrossRefPubMedPubMedCentral
15.
go back to reference de Lorenzo C, Xikota J, Wayhs M, Nassar S, de Souza Pires M: Evaluation of the quality of life of children with celiac disease and their parents: a case–control study. Qual Life Res. 2012, 21: 77-85. 10.1007/s11136-011-9930-7.CrossRefPubMed de Lorenzo C, Xikota J, Wayhs M, Nassar S, de Souza Pires M: Evaluation of the quality of life of children with celiac disease and their parents: a case–control study. Qual Life Res. 2012, 21: 77-85. 10.1007/s11136-011-9930-7.CrossRefPubMed
16.
go back to reference Byström I-M, Hollén E, Fälth-Magnusson K, Johansson A: Health-related quality of life in children and adolescents with celiac disease: from the perspectives of children and parents. Gastroenterology Research and Practice. 2012, 2012: 6-CrossRef Byström I-M, Hollén E, Fälth-Magnusson K, Johansson A: Health-related quality of life in children and adolescents with celiac disease: from the perspectives of children and parents. Gastroenterology Research and Practice. 2012, 2012: 6-CrossRef
17.
go back to reference Lee A, Newman JM: Celiac diet: its impact on quality of life. J Am Diet Assoc. 2003, 103: 1533-1535. 10.1016/j.jada.2003.08.027.CrossRefPubMed Lee A, Newman JM: Celiac diet: its impact on quality of life. J Am Diet Assoc. 2003, 103: 1533-1535. 10.1016/j.jada.2003.08.027.CrossRefPubMed
18.
go back to reference Hallert C, Grannö C, Grant C, Hulten S, Midhagen G, Ström M, Svensson H, Valdimarsson T, Wickström T: Quality of life of adult coeliac patients treated for 10 years. Scand J Gastroenterol. 1998, 33: 933-938. 10.1080/003655298750026949.CrossRefPubMed Hallert C, Grannö C, Grant C, Hulten S, Midhagen G, Ström M, Svensson H, Valdimarsson T, Wickström T: Quality of life of adult coeliac patients treated for 10 years. Scand J Gastroenterol. 1998, 33: 933-938. 10.1080/003655298750026949.CrossRefPubMed
19.
go back to reference Mustalahti K, Lohiniemi S, Collin P, Vuolteenaho N, Laippala P, Mäki M: Gluten-free diet and quality of life in patients with screen-detected celiac disease. Eff Clin Pract. 2002, 5: 105-113.PubMed Mustalahti K, Lohiniemi S, Collin P, Vuolteenaho N, Laippala P, Mäki M: Gluten-free diet and quality of life in patients with screen-detected celiac disease. Eff Clin Pract. 2002, 5: 105-113.PubMed
20.
go back to reference Ciacci C, D’Agate C, De Rosa A, Franzese C, Errichiello S, Gasperi V, Pardi A, Quagliata D, Visentini S, Greco L: Self-rated quality of life in celiac disease. Dig Dis Sci. 2003, 48: 2216-2220.CrossRefPubMed Ciacci C, D’Agate C, De Rosa A, Franzese C, Errichiello S, Gasperi V, Pardi A, Quagliata D, Visentini S, Greco L: Self-rated quality of life in celiac disease. Dig Dis Sci. 2003, 48: 2216-2220.CrossRefPubMed
21.
go back to reference Casellas F, Rodrigo L, Vivancos JL, Riestra S, Pantiga C, Baudet JS, Junquera F, Divi VP, Abadia C, Papo M, et al: Factors that impact health-related quality of life in adults with celiac disease to multicenter study. World J Gastroenterol. 2008, 14: 46-52. 10.3748/wjg.14.46.CrossRefPubMedPubMedCentral Casellas F, Rodrigo L, Vivancos JL, Riestra S, Pantiga C, Baudet JS, Junquera F, Divi VP, Abadia C, Papo M, et al: Factors that impact health-related quality of life in adults with celiac disease to multicenter study. World J Gastroenterol. 2008, 14: 46-52. 10.3748/wjg.14.46.CrossRefPubMedPubMedCentral
22.
go back to reference Paavola A, Kurppa K, Ukkola A, Collin P, Lähdeaho M-L, Huhtala H, Mäki M, Kaukinen K: Gastrointestinal symptoms and quality of life in screen-detected celiac disease. Dig Liver Dis. 2012, 44: 814-818. 10.1016/j.dld.2012.04.019.CrossRefPubMed Paavola A, Kurppa K, Ukkola A, Collin P, Lähdeaho M-L, Huhtala H, Mäki M, Kaukinen K: Gastrointestinal symptoms and quality of life in screen-detected celiac disease. Dig Liver Dis. 2012, 44: 814-818. 10.1016/j.dld.2012.04.019.CrossRefPubMed
23.
go back to reference Tontini GE, Rondonotti E, Saladino V, Saibeni S, de Franchis R, Vecchi M: Impact of gluten withdrawal on health-related quality of life in celiac subjects: an observational case–control study. Digestion. 2010, 82: 221-228. 10.1159/000265549.CrossRefPubMed Tontini GE, Rondonotti E, Saladino V, Saibeni S, de Franchis R, Vecchi M: Impact of gluten withdrawal on health-related quality of life in celiac subjects: an observational case–control study. Digestion. 2010, 82: 221-228. 10.1159/000265549.CrossRefPubMed
24.
go back to reference Ukkola A, Mäki M, Kurppa K, Collin P, Huhtala H, Kekkonen L, Kaukinen K: Diet improves perception of health and well-being in symptomatic, but not asymptomatic, patients With celiac disease. Clin Gastroenterol Hepatol. 2011, 9: 118-123. 10.1016/j.cgh.2010.10.011. e111CrossRefPubMed Ukkola A, Mäki M, Kurppa K, Collin P, Huhtala H, Kekkonen L, Kaukinen K: Diet improves perception of health and well-being in symptomatic, but not asymptomatic, patients With celiac disease. Clin Gastroenterol Hepatol. 2011, 9: 118-123. 10.1016/j.cgh.2010.10.011. e111CrossRefPubMed
25.
go back to reference Whitaker JKH, West J, Holmes GKT, Logan RFA: Patient perceptions of the burden of coeliac disease and its treatment in the UK. Aliment Pharmacol Ther. 2009, 29: 1131-1136. 10.1111/j.1365-2036.2009.03983.x.CrossRefPubMed Whitaker JKH, West J, Holmes GKT, Logan RFA: Patient perceptions of the burden of coeliac disease and its treatment in the UK. Aliment Pharmacol Ther. 2009, 29: 1131-1136. 10.1111/j.1365-2036.2009.03983.x.CrossRefPubMed
26.
go back to reference Viljamaa M, Collin P, Huhtala H, Sievanen H, Mäki M, Kaukinen K: Is coeliac disease screening in risk groups justified? A fourteen-year follow-up with special focus on compliance and quality of life. Aliment Pharmacol Ther. 2005, 22: 317-324. 10.1111/j.1365-2036.2005.02574.x.CrossRefPubMed Viljamaa M, Collin P, Huhtala H, Sievanen H, Mäki M, Kaukinen K: Is coeliac disease screening in risk groups justified? A fourteen-year follow-up with special focus on compliance and quality of life. Aliment Pharmacol Ther. 2005, 22: 317-324. 10.1111/j.1365-2036.2005.02574.x.CrossRefPubMed
27.
go back to reference Norström F, Lindholm L, Sandström O, Nordyke K, Ivarsson A: Delay to celiac disease diagnosis and its implications for health-related quality of life. BMC Gastroenterol. 2011, 11: 118-10.1186/1471-230X-11-118.CrossRefPubMedPubMedCentral Norström F, Lindholm L, Sandström O, Nordyke K, Ivarsson A: Delay to celiac disease diagnosis and its implications for health-related quality of life. BMC Gastroenterol. 2011, 11: 118-10.1186/1471-230X-11-118.CrossRefPubMedPubMedCentral
28.
go back to reference Nachman F, Maurino E, Vazquez H, Sfoggia C, Gonzalez A, Gonzalez V, Plancer del Campo M, Smecuol E, Niveloni S, Sugai E: Quality of life in celiac disease patients: prospective analysis on the importance of clinical severity at diagnosis and the impact of treatment. Dig Liver Dis. 2009, 41: 15-25. 10.1016/j.dld.2008.05.011.CrossRefPubMed Nachman F, Maurino E, Vazquez H, Sfoggia C, Gonzalez A, Gonzalez V, Plancer del Campo M, Smecuol E, Niveloni S, Sugai E: Quality of life in celiac disease patients: prospective analysis on the importance of clinical severity at diagnosis and the impact of treatment. Dig Liver Dis. 2009, 41: 15-25. 10.1016/j.dld.2008.05.011.CrossRefPubMed
29.
go back to reference Ravens-Sieberer U, Wille N, Badia X, Bonsel G, Burström K, Cavrini G, Devlin N, Egmar AC, Gusi N, Herdman M, et al: Feasibility, reliability, and validity of the EQ-5D-Y: results from a multinational study. Qual Life Res. 2010, 19: 887-897. 10.1007/s11136-010-9649-x.CrossRefPubMedPubMedCentral Ravens-Sieberer U, Wille N, Badia X, Bonsel G, Burström K, Cavrini G, Devlin N, Egmar AC, Gusi N, Herdman M, et al: Feasibility, reliability, and validity of the EQ-5D-Y: results from a multinational study. Qual Life Res. 2010, 19: 887-897. 10.1007/s11136-010-9649-x.CrossRefPubMedPubMedCentral
30.
go back to reference Burström K, Egmar AC, Lugner A, Eriksson M, Svartengren M: A Swedish child-friendly pilot version of the EQ-5D instrument-the development process. Eur J Public Health. 2011, 21: 171-177. 10.1093/eurpub/ckq037.CrossRefPubMed Burström K, Egmar AC, Lugner A, Eriksson M, Svartengren M: A Swedish child-friendly pilot version of the EQ-5D instrument-the development process. Eur J Public Health. 2011, 21: 171-177. 10.1093/eurpub/ckq037.CrossRefPubMed
31.
go back to reference Burström K, Svartengren M, Egmar AC: Testing a Swedish child-friendly pilot version of the EQ-5D instrument-initial results. Eur J Public Health. 2011, 21: 178-183. 10.1093/eurpub/ckq042.CrossRefPubMed Burström K, Svartengren M, Egmar AC: Testing a Swedish child-friendly pilot version of the EQ-5D instrument-initial results. Eur J Public Health. 2011, 21: 178-183. 10.1093/eurpub/ckq042.CrossRefPubMed
32.
go back to reference Brooks R, Rabin R, De Charro F: The measurement and valuation of health status using EQ-5D: A European perspective. 2003, The Netherlands: Kluwer Academic PublishersCrossRef Brooks R, Rabin R, De Charro F: The measurement and valuation of health status using EQ-5D: A European perspective. 2003, The Netherlands: Kluwer Academic PublishersCrossRef
33.
go back to reference Cheung K, Oemar M, Oppe M, Rosalind R: EQ-5D user guide. Basic information on how to use EQ-5D. www.euroqol.org. 2009 Cheung K, Oemar M, Oppe M, Rosalind R: EQ-5D user guide. Basic information on how to use EQ-5D. www.euroqol.org. 2009
34.
go back to reference Nordyke K, Norström F, Lindholm L, Carlsson A, Danielsson L, Emmelin M, Högberg L, Karlsson E, Ivarsson A: Health-related quality-of-life in children with coeliac disease, measured prior to receiving their diagnosis through screening. J Med Screen. 2011, 18: 187-192. 10.1258/jms.2011.011081.CrossRefPubMed Nordyke K, Norström F, Lindholm L, Carlsson A, Danielsson L, Emmelin M, Högberg L, Karlsson E, Ivarsson A: Health-related quality-of-life in children with coeliac disease, measured prior to receiving their diagnosis through screening. J Med Screen. 2011, 18: 187-192. 10.1258/jms.2011.011081.CrossRefPubMed
35.
go back to reference Van Koppen EJ, Schweizer JJ, Csizmadia C, Krom Y, Hylkema HB, van Geel AM, Koopman HM, Verloove-Vanhorick P, Mearin ML: Long-term health and quality-of-life consequences of mass screening for childhood celiac disease: a 10-year follow-up study. Pediatrics. 2009, 123: E582-E588. 10.1542/peds.2008-2221.CrossRefPubMed Van Koppen EJ, Schweizer JJ, Csizmadia C, Krom Y, Hylkema HB, van Geel AM, Koopman HM, Verloove-Vanhorick P, Mearin ML: Long-term health and quality-of-life consequences of mass screening for childhood celiac disease: a 10-year follow-up study. Pediatrics. 2009, 123: E582-E588. 10.1542/peds.2008-2221.CrossRefPubMed
36.
go back to reference Johnston SD, Rodgers C, Watson RGP: Quality of life in screen-detected and typical coeliac disease and the effect of excluding dietary gluten. Eur J Gastroenterol Hepatol. 2004, 16: 1281-1286. 10.1097/00042737-200412000-00008.CrossRefPubMed Johnston SD, Rodgers C, Watson RGP: Quality of life in screen-detected and typical coeliac disease and the effect of excluding dietary gluten. Eur J Gastroenterol Hepatol. 2004, 16: 1281-1286. 10.1097/00042737-200412000-00008.CrossRefPubMed
37.
go back to reference Rosén A, Ivarsson A, Nordyke K, Karlsson E, Carlsson A, Danielsson L, Högberg L, Emmelin M: Balancing health benefits and social sacrifices: a qualitative study of how screening-detected celiac disease impacts adolescents’ quality of life. BMC Pediatr. 2011, 11: 32-10.1186/1471-2431-11-32.CrossRefPubMedPubMedCentral Rosén A, Ivarsson A, Nordyke K, Karlsson E, Carlsson A, Danielsson L, Högberg L, Emmelin M: Balancing health benefits and social sacrifices: a qualitative study of how screening-detected celiac disease impacts adolescents’ quality of life. BMC Pediatr. 2011, 11: 32-10.1186/1471-2431-11-32.CrossRefPubMedPubMedCentral
38.
go back to reference Ivarsson A, Persson L, Nyström L, Hernell O: The Swedish coeliac disease epidemic with a prevailing twofold higher risk in girls compared to boys may reflect gender specific risk factors. Eur J Epidemiol. 2003, 18: 677-684.CrossRefPubMed Ivarsson A, Persson L, Nyström L, Hernell O: The Swedish coeliac disease epidemic with a prevailing twofold higher risk in girls compared to boys may reflect gender specific risk factors. Eur J Epidemiol. 2003, 18: 677-684.CrossRefPubMed
39.
go back to reference Hallert C, Sandlund O, Broqvist M: Perceptions of health-related quality of life of men and women living with coeliac disease. Scand J Caring Sci. 2003, 17: 301-307. 10.1046/j.1471-6712.2003.00228.x.CrossRefPubMed Hallert C, Sandlund O, Broqvist M: Perceptions of health-related quality of life of men and women living with coeliac disease. Scand J Caring Sci. 2003, 17: 301-307. 10.1046/j.1471-6712.2003.00228.x.CrossRefPubMed
40.
go back to reference Sverker A, Ostlund G, Hallert C, Hensing G: ‘I lose all these hours…’ - exploring gender and consequences of dilemmas experienced in everyday life with coeliac disease. Scand J Caring Sci. 2009, 23: 342-352. 10.1111/j.1471-6712.2008.00628.x.CrossRefPubMed Sverker A, Ostlund G, Hallert C, Hensing G: ‘I lose all these hours…’ - exploring gender and consequences of dilemmas experienced in everyday life with coeliac disease. Scand J Caring Sci. 2009, 23: 342-352. 10.1111/j.1471-6712.2008.00628.x.CrossRefPubMed
41.
go back to reference Will C: Constructions of masculinity and their influence on men’s well-being:a theory of gender and health. Soc Sci Med. 2000, 50: 1385-1401. 10.1016/S0277-9536(99)00390-1.CrossRef Will C: Constructions of masculinity and their influence on men’s well-being:a theory of gender and health. Soc Sci Med. 2000, 50: 1385-1401. 10.1016/S0277-9536(99)00390-1.CrossRef
43.
go back to reference Marcell A, Ford C, Pleck J, Sonenstein F: Masculine beliefs, parental communication, and male adolescents’ health care use. Pediatrics. 2007, 119: 966-975. 10.1542/peds.2006-1683.CrossRef Marcell A, Ford C, Pleck J, Sonenstein F: Masculine beliefs, parental communication, and male adolescents’ health care use. Pediatrics. 2007, 119: 966-975. 10.1542/peds.2006-1683.CrossRef
44.
go back to reference Kolsteren MMP, Koopman HM, Schalekamp G, Mearin ML: Health-related quality of life in children with celiac disease. J Pediatr. 2001, 138: 593-595. 10.1067/mpd.2001.111504.CrossRefPubMed Kolsteren MMP, Koopman HM, Schalekamp G, Mearin ML: Health-related quality of life in children with celiac disease. J Pediatr. 2001, 138: 593-595. 10.1067/mpd.2001.111504.CrossRefPubMed
45.
go back to reference Ljungman G, Myrdal U: Compliance in teenagers with celiac-disease -a Swedish follow-up-study. Acta Paediatr. 1993, 82: 235-238. 10.1111/j.1651-2227.1993.tb12649.x.CrossRefPubMed Ljungman G, Myrdal U: Compliance in teenagers with celiac-disease -a Swedish follow-up-study. Acta Paediatr. 1993, 82: 235-238. 10.1111/j.1651-2227.1993.tb12649.x.CrossRefPubMed
Metadata
Title
Health-related quality of life in adolescents with screening-detected celiac disease, before and one year after diagnosis and initiation of gluten-free diet, a prospective nested case-referent study
Authors
Katrina Nordyke
Fredrik Norström
Lars Lindholm
Hans Stenlund
Anna Rosén
Anneli Ivarsson
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2013
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-13-142

Other articles of this Issue 1/2013

BMC Public Health 1/2013 Go to the issue